CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat rare and serious conditions that include immunodeficiency and autoimmune diseases, hereditary and acquired bleeding disorders, hereditary angioedema, hereditary emphysema, and in transplantation and critical care.
